Three regimens for re-treatment failure of Sofosbuvir-based therapy for chronic hepatitis-C genotype-4: a cohort study

Despite the high sustained virologic response (SVR) rates of direct-acting antiviral (DAAs) therapy, a small number of patients does not eradicate the virus, and these patients represent a challenge. This study aims to compare the outcomes of three second-line regimens for DAAs-experienced patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Shousha, Hend Ibrahim, Abdelghafour, Reem, Dabees, Hosam, AbdelRazek, Wael, Said, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto de Medicina Tropical de São Paulo 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448256/
https://www.ncbi.nlm.nih.gov/pubmed/36074445
http://dx.doi.org/10.1590/S1678-9946202264050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448256/
https://www.ncbi.nlm.nih.gov/pubmed/36074445
http://dx.doi.org/10.1590/S1678-9946202264050

Ejemplares similares